In conversation with BioPharma BoardRoom, Amanda Haupt, Business Unit Manager for Base Editing at Revvity, shares insights into how the company’s collaboration with Profluent is redefining what’s possible in gene editing. ... Read more
Illumina Inc. (NASDAQ: ILMN) will partner with multiple global pharmaceutical companies to develop companion diagnostics (CDx) enabled on the TruSight™ Oncology (TSO) Comprehensive genomic profiling test. The continued expansio... Read more
Pierre Boulud, Chief Executive Officer of bioMérieux, set the tone for the company’s first-half 2025 performance: “With a strong increase in profitability in the first half of 2025, bioMérieux confirms the relevance... Read more
The founder and long-standing CEO of PlasmidFactory GmbH, Dr. Martin Schleef, was honored in Düsseldorf with the Innovation Award 2025 of the State of North Rhine-Westphalia. The award is one of Germany's most prestigious innovation awards an... Read more
Santhera secures approximately CHF 20 million of additional funding from existing investors Highbridge and R-Bridge to accelerate global rollout Demand for AGAMREE® (vamorolone) in US/China ahead of plan; increased inventory needs and launch... Read more
Yatiri Bio Inc. announced it has received a grant from the Gates Foundation to launch a one-year project, Proteomics Interoperability, aimed at improving how large-scale proteomics data can be integrated and applied to global health challenge... Read more
Members of Management and Business Development will be at BioProcess International Asia in Kyoto, Japan, October 20-22, 2025 Company will introduce the Rentschler Expression Platform for accelerated timelines in Cell Line Development and Rentsch... Read more
Avobis Bio LLC, a clinical-stage company developing implantable cell therapies, announced that the U.S. Food and Drug Administration ("FDA") has granted Regenerative Medicine Advanced Therapy ("RMAT") designation for AVB-114, the Company's le... Read more
© 2025 Biopharma Boardroom. All Rights Reserved.
